CIC
SGMO

Cornercap Investment Counsel’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Cornercap Investment Counsel’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-90,265
Closed -$117K – 651
2023
Q2 		$117K Buy
90,265
+3,331
+4% +$4.55K 0.02% 541
2023
Q1 		$153K Buy
86,934
+19,024
+28% +$54.3K 0.03% 524
2022
Q4 		$213K Buy
67,910
+17,545
+35% +$68.1K 0.04% 512
2022
Q3 		$247K Buy
50,365
+15,704
+45% +$80.7K 0.05% 465
2022
Q2 		$143K Buy
+34,661
New +$150K 0.02% 509

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Cornercap Investment Counsel's SGMO Position: Q3 2023 in Review

Cornercap Investment Counsel sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2023, closing a stake of 90,265 shares — an estimated $117K sold.

Cornercap Investment Counsel first reported a position in SGMO in Q2 2022 and held it in 5 quarters. The position peaked at $247K in Q3 2022. 134 funds tracked by Wall St. Rank hold SGMO as of Q3 2023.

  • Cornercap Investment Counsel reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2023 after selling out during the quarter.
  • Cornercap Investment Counsel sold 90,265 SANGAMO THERAPEUTICS INC shares in Q3 2023, an estimated $117K.
  • Cornercap Investment Counsel first reported a position in SANGAMO THERAPEUTICS INC in Q2 2022 and held it in 5 quarters.
  • Cornercap Investment Counsel's SANGAMO THERAPEUTICS INC position peaked at $247K in Q3 2022.
  • 134 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2023.

Based on Cornercap Investment Counsel's 13F filing for Q3 2023, filed 13 Nov 2023.